The APC/C and CBP/p300 cooperate to regulate transcription and cell-cycle progression

Nature

Volumn 438, Issue 7068, 2005, Pages 690-695

  Turnell, Andrew S ^a   Stewart, Grant S ^a,b   Grand, Roger J A ^a   Rookes, Susan M ^a   Martin, Ashley ^a   Yamano, Hiroyuki ^c   Elledge, Stephen J ^b,d   Gallimore, Phillip H ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c MARIE CURIE RESEARCH INSTITUTE   (United Kingdom)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALYST ACTIVITY; DEGRADATION; FUNCTIONS; PROTEINS; SUBSTRATES;

CELL-CYCLE PROGRESSION; EUKARYOTIC CELLS; MULTI-COMPONENT E3 UBIQUITIN;

CELL CULTURE;

ANAPHASE PROMOTING COMPLEX; RNA; UBIQUITIN PROTEIN LIGASE;

MEDICINE;

ARTICLE; CELL CYCLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME REGULATION; EUKARYOTE; GENE CONTROL; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

ADENOVIRIDAE; EUKARYOTA;

EID: 28444451188     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature04151     Document Type: Article

References (30)

1. Harper, J. W., Burton, J. L. & Solomon, M. J. The anaphase-promoting complex: it's not just for mitosis anymore. Genes Dev. 16, 2179-2206 (2002).
2. Peters, J.-M. The anaphase-promoting complex: proteolysis in mitosis and beyond. Mol. Cell 9, 931-943 (2002).
3. Cdh1 ubiquitin ligase. Nature 428, 190-193 (2004).
4. Wei, W. et al. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature 428, 194-198 (2004).
5. Eckner, R. et al. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8, 869-884 (1994).
6. Lundblad, J. R., Kwok, R. P. S., Laurance, M. E., Harter, M. L. & Goodman, R. H. Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature 374, 85-88 (1995).
7. O'Connor, M. J., Zimmermann, H., Nielsen, S., Bernard, H.-U. & Kouzarides, T. Characterization of an E1A-CBP interaction defines a novel transcriptional adapter motif (TRAM) in CBP/p300. J. Virol. 73, 3574-3581 (1999).
8. Gallimore, P. H. & Turnell, A. S. Adenovirus E1A: remodelling the host cell, a life or death experience. Oncogene 20, 7824-7835 (2001).
9. Vodermaier, H. C., Gieffers, C., Maurer-Stroh, S., Eisenhaber, F. & Peters, J.-M. TPR subunits of the anaphase-promoting complex mediate binding to the activator protein CDH1. Curr. Biol. 13, 1459-1468 (2003).
10. Turnell, A. S. et al. Regulation of the 26S proteasome by adenovirus E1A. EMBO J. 19, 4759-4773 (2000).
11. Zhang, X. et al. The targeting of the proteasomal regulatory subunit S2 by adenovirus E1A causes inhibition of proteasomal activity and increased p53 expression. J. Biol. Chem. 279, 25122-25133 (2004).
12. Kwok, R. P. S. et al. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370, 223-226 (1994).
13. Bannister, A. J. & Kouzarides, T. The CBP coactivator is a histone acetyltransferase. Nature 384, 641-643 (1996).
14. Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H. & Nakatani, Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87, 953-959 (1996).
15. Yuan, W., Condorelli, G., Caruso, M., Felasani, A. & Giordano, A. Human p300 protein is a coactivator for the transcription factor MyoD. J. Biol. Chem. 271, 9009-9013 (1996).
16. Chakravarti, D. et al. Role of CBP/p300 in nuclear receptor signalling. Nature 383, 99-103 (1996).
17. Kamei, Y. et al. A CBP integrator complex mediates transcriptionai activation and AP-1 inhibition by nuclear receptors. Cell 85, 403-414 (1996).
18. Gu, W., Shi, X. L. & Roeder, R. G. Synergistic activation of transcription by CBP and p53. Nature 387, 819-823 (1997).
19. Lill, N. L., Grossman, S. R., Ginsberg, D., DeCaprio, J. & Livingston, D. M. Binding and modulation of p53 by p300/CBP coactivators. Nature 387, 823-827 (1997).
20. Avantaggiati, M. L. et al. Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89, 1175-1184 (1997).
21. Trouche, D., Cook, A. & Kouzarides, T. The CBP co-activator stimulates E2F1/DP1 activity. Nucleic Acids Res. 24, 4139-4145 (1996).
22. El-Deiry, W. S. et al. WAF1, a potential mediator of p53 tumour suppression. Cell 75, 817-825 (1993).
23. Thompson, P. R. et al. Regulation of the p300 HAT domain via a novel activation loop. Nature Struct. Mol. Biol. 11, 308-315 (2004).
24. Salghetti, S. E., Kim, S. Y. & Tansey, W. P. Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J. 18, 717-726 (1999).
25. Lillie, J. W., Green, M. & Green, M. R. An adenovirus E1a protein region required for transformation and transcriptional repression. Cell 46, 1043-1045 (1986).
26. Jelsma, T. N. et al. Sequences in E1A proteins of human adenovirus 5 required for cell transformation, repression of a transcriptional enhancer, and induction of proliferating cell nuclear antigen. Virology 170, 120-130 (1989).
27. Wang, H. G. H. et al. Identification of specific adenovirus-E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth. J. Virol. 67, 476-488 (1993),
28. Grossmann, S. R. et al. Polyubiquitination of p53 by a ubiquitin ligase activity of p300. Science 300, 342-344 (2003).
29. Goodman, R. H. & Smolik, S. CBP/p300 in cell growth, transformation and development. Genes Dev. 14, 1553-1577 (2000).
30. Kramer, E. R., Gieffers, C., Holzl, G., Hengstschlager, M. & Peters, J. M. Activation of the human anaphase-promoting complex by proteins of the CDC20/Fizzy family. Curr. Biol. 8, 1207-1210 (1998).